As the number of coronavirus cases in the world exceeds 1.4 million, the pharma industry is pushing to find new drugs, therapies and tests in the effort to bring the pandemic under control.
Johnson & Johnson has announced plans to team up with the US government to invest more than $1 billion in a new vaccine against COVID-19, aiming to begin clinical trials by September.<
Sanofi’s Pasteur vaccines unit has joined with the US biotech Translate Bio to announce a partnership to develop an mRNA vaccine against the coronavirus that causes the COVID-19 pandemic.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
